✦ LIBER ✦

P1177 TREATMENT OF CHRONIC HEPATITIS C IN THE AGED – DOES IT IMPACT LIFE EXPECTANCY? – A DECISION ANALYSIS

✍ Scribed by Maor, Y.; Malnick, S.D.; Melzer, E.; Leshno, M.

Book ID: 122232183
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 54 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61337-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chronic hepatitis C virus infection: Doe

Chronic hepatitis C virus infection: Does it really impact health-related quality of life? A study in rural Egypt

✍ Michaël Schwarzinger; Sahar Dewedar; Claire Rekacewicz; Khaled Mahmoud Abd Elazi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

Previous Western studies showed a consistent and marked reduction in health-related quality of life (HRQOL) in patients chronically infected with hepatitis C virus (HCV). However, these studies were conducted on patients whose knowledge of their serological status may have affected their HRQOL. This

Does the use of different standardized H

Does the use of different standardized HCV RNA quantification methods influence the decision of treatment duration in chronic hepatitis C?

✍ N. Fernandez; B. Padriali; J. Fernandez; J. Findor; H. Tanno; R. Terg; A. Gadano 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 152 KB

P663 IMPACT OF HEPATIC FLARE ON THE LONG

P663 IMPACT OF HEPATIC FLARE ON THE LONG-TERM DECLINE IN HEPATITIS B SURFACE ANTIGEN TOWARD ITS SEROCLEARANCE IN CHRONIC HBV CARRIERS: A SINGLE CENTER RETROSPECTIVE ANALYSIS

✍ Nagaoka, S.; Shiota, J.; Kugiyama, Y.; Miyazoe, Y.; Sasaki, R.; Bekki, S.; Hashi 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Effectiveness and cost-effectiveness of

Effectiveness and cost-effectiveness of initial antiviral treatment in patients with chronic hepatitis C. A German health technology assessment and decision analysis commissioned by the German Federal Ministry of Health

✍ U. Siebert; G. Sroczynski 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Sa1051 Boceprevir Based Triple Therapy i

Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 646 KB

Sa1050 Efficacy of Boceprevir Based Trip

Sa1050 Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 315 KB